Key result
Worry about side effects is linked to ~90% higher odds of intentional statin non-adherence.
Cross-Sectional (n=229)
Yes
Answers are grounded in this paper and cite their sources.
BACKGROUND: Non-adherence to statins is substantial and is associated with numerous perceptions and experiences. However, time limits in clinical practice constrain in depth explorations of these perceptions and experiences. OBJECTIVES: To propose and examine a strategy aimed at an efficient assessment of a wide array of perceptions and experiences regarding the efficacy, side effects, and practical problems of statins. Furthermore, to assess associations between this wide array of experiences and perceptions and non-adherence and to examine whether patients' 'perceived self-efficacy' moderated these associations. METHODS: Patients were recruited through community pharmacies. A wide array of specific patient perceptions and experiences was efficiently assessed using the electronic Tailored Medicine Inventory that allows people to skip irrelevant questions. Adherence was measured through self-report and pharmacy refill data. RESULTS: Of the two-hundred twenty-nine patients who participated (mean age 63.9, standard deviation 10.2), 40%-70% doubted the necessity of or lacked knowledge about the efficacy of statins, 20%-35% of the patients were worried about joint and muscle side effects or had experienced these, and 23% had encountered practical problems regarding information about statins, intake of tablets, the package, or the blister. Experiencing more practical problems was associated with increased unintentional non-adherence (Odds ratio 1.54, 95%CI:1.13-2.10, P < 0.01), whereas worrying about side effects was associated with increased intentional non-adherence (Odds ratio 1.90, 95%CI:1.17-3.08, P < 0.01). Higher 'perceived self-efficacy' did not moderate these associations. CONCLUSIONS: Insight into patients' specific barriers with regard to appropriate statin use may reveal personal reasons for being non-adherent. The Tailored Medicine Inventory is a promising tool to devise individualized intervention strategies aimed at improving adherence by the clinician-patient alliance.
No takes yet. Share an insight, caveat, or question.
Wouters et al. (2016) conducted a cross-sectional in Statin use / non-adherence (n=229). Patient perceptions and practical problems regarding statins (assessed via Tailored Medicine Inventory) vs. Fewer practical problems or worries about side effects was evaluated on Unintentional and intentional statin non-adherence (measured via self-report and pharmacy refill data) (OR 1.90, 95% CI 1.17-3.08, p=<0.01). Worrying about statin side effects increased intentional non-adherence, while practical problems increased unintentional non-adherence.
Synapse has enriched 10 related papers. Consider them for comparative context: